|
Volumn 349, Issue 9047, 1997, Pages 258-
|
US expert panel reaffirms benefit of perinatal zidovudine.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DISEASE TRANSMISSION;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MOUSE;
PREGNANCY;
PREGNANCY COMPLICATION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANIMALS;
ANTI-HIV AGENTS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV-1;
HUMANS;
MICE;
NEOPLASMS, EXPERIMENTAL;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
ZIDOVUDINE;
|
EID: 0031585758
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)64869-6 Document Type: Article |
Times cited : (1)
|
References (0)
|